New Fellowship by the Stanford Mussallem Center for Biodesign and Impact1 Empowers Next Generation of Innovators to Tackle Congenital Heart Defects
Supported by a new grant from the Mussallem CHD Alliance, the Stanford Mussallem Center for Biodesign and Impact1 this week launched the Mussallem CHD Alliance Innovation Fellowship, which will empower fellows to apply the rigorous Stanford Biodesign process to tackle some of the most pressing challenges in congenital heart defect (CHD) care, fostering solutions that can improve patient treatment and outcomes.
The Mussallem CHD Alliance Innovation Fellowship is a full-time, 10-month paid academic opportunity designed for individuals who have completed prior Stanford Biodesign training. Fellows will immerse themselves in clinical environments, conduct needs research, and develop innovative solutions for CHD, with support from clinical faculty and access to resources that accelerate translation from concept to reality.
“Stanford Biodesign’s proven approach to need-driven innovation and Impact1’s focus on accelerating pediatric health solutions will foster an exceptional environment for developing breakthrough CHD concepts,” said Orin Herskowitz, President of the Mussallem CHD Alliance. “We believe these fellows will help drive real innovation and change, turning bold ideas into tangible advances that can transform lives.”
The fellowship program will build upon the CHD needs analysis conducted by Dr. Ignacio Pérez, Stanford Biodesign’s inaugural Edwards Lifesciences CHD Fellow, which developed a comprehensive representation of over 200 of the most pressing unmet needs in the CHD landscape in the United States.
Interested candidates who have completed eligible Stanford Biodesign training can submit their applications and find more information at https://bit.ly/CHDfellowship.